NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday:
Immunovant Inc., up $1.18 to $34.66.
The biotechnology company reported encouraging results from a study of its potential treatment for a muscle fatigue condition.
Amgen Inc., up $12.65 to $248.22.
The biotechnology giant will be added to the Dow Jones Industrial Average on Aug. 31 as part of an index shakeup.
Medtronic Plc., up $2.46 to $102.59.
The medical device company handily beat Wall Street's fiscal first-quarter profit and revenue forecasts.
Children’s Place Inc., down $4.39 to $18.92.
The children’s clothing and accessories chain reported disappointing second-quarter earnings and revenue.
Tiffany & Co., down $5.04 to $121.99.
The jeweler's purchase by LVMH was pushed back three months to Nov. 24.
Best Buy Co., down $4.73 to $112.64.
The electronics retailer did not provide a financial forecast and warned its sales growth could slow during the third quarter.
Hormel Foods Corp., down $1.10 to $51.54.
The maker of Dinty Moore stew and Skippy peanut butter warned that it could have trouble meeting demand in the fourth quarter.
J.M. Smucker Co., up $7.76 to $120.75.
The maker of Jif peanut butter and Folgers coffee reported good quarterly earnings and raised its financial forecasts.
Before you consider J. M. Smucker, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and J. M. Smucker wasn't on the list.
While J. M. Smucker currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
